Abstract

COVID-19 after BNT162b2 two-dose primary series does not improve the efficacy of a booster dose in nursing home residents.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Decision letter: Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial
Jameel Iqbal ... Mone Zaidi
-
Jameel Iqbal, et. al.Jameel Iqbal ... Mone Zaidi
09 Feb 2023
Editor's evaluation: Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial
Jameel Iqbal
-
Jameel IqbalJameel Iqbal
09 Feb 2023
Author response: Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial
Astha Thakkar ...
-
Astha Thakkar, et. al.Astha Thakkar ...
27 Feb 2023
A Third Dose of mRNA COVID-19 Vaccine Significantly Enhances Anti-SARS-CoV-2 Spike IgG Response in Nursing Home Residents in Italy.
Giorgio Fedele ... Francesco Talarico
Journal of the American Medical Directors Association | VOL. 23
Giorgio Fedele, et. al.Giorgio Fedele ... Francesco Talarico
16 May 2022
View more papers

More From: Clinical and translational allergy

Paper Title
Journal
Date
Author
-
-
Clinical and Translational Allergy | VOL. 14
--
01 Aug 2024
Milk ladder versus early oral immunotherapy in infants with cow's milk protein allergy.
Yurika Matsumoto ... Chisato Inuo
Clinical and translational allergy | VOL. 14
Yurika Matsumoto, et. al.Yurika Matsumoto ... Chisato Inuo
01 Aug 2024
Clinical and biological characteristics associated with bronchial or pulmonary abnormalities on chest CT imaging in patients with systemic mastocytosis.
Raphael Vallière ... Laurent Guilleminault
Clinical and translational allergy | VOL. 14
Raphael Vallière, et. al.Raphael Vallière ... Laurent Guilleminault
01 Aug 2024
Issue Information
-
Clinical and Translational Allergy | VOL. 14
--
28 Jul 2024
View more papers